The company has a market capitalization of $102,240.00, a price-to-earnings ratio of 24.59, a PEG ratio of 2.22 and a beta of 1.18. The firm owned 50,348 shares of the biopharmaceutical company's stock after acquiring an additional 8,925 shares during the quarter. BMY has diverse figures for different time frames; starting from week's performance plunged 1.17% in last five regular trading sessions.
First Financial Bank Trust Division lowered its position in Bristol-Myers Squibb Co (NYSE:BMY) by 65.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. It has underperformed by 39.89% the S&P500.
Pembroke Management Ltd increased its stake in Albany Intl Corp (AIN) by 23.81% based on its latest 2017Q3 regulatory filing with the SEC. When we look at the Volatility of the company, Week Volatility is at 1.25% whereas Month Volatility is at 1.40%. Chilton Investment Co. LLC now owns 5,283 shares of the biopharmaceutical company's stock worth $294,000 after purchasing an additional 26 shares in the last quarter. Perkins Coie Trust Co now owns 2,239 shares of the biopharmaceutical company's stock valued at $121,000 after buying an additional 68 shares during the period. In the last month, the price of K has increased +0.05%. About 131,116 shares traded. PetrÃ³leo Brasileiro S.A. - Petrobras (NYSE:PBR) has risen 39.56% since January 11, 2017 and is uptrending. It has outperformed by 3.87% the S&P500. It also reduced its holding in Arista Networks In (NYSE:ANET) by 9,400 shares in the quarter, leaving it with 53,100 shares, and cut its stake in Acadia Healthcare (NASDAQ:ACHC).
Investors sentiment increased to 1.26 in 2017 Q3. Its up 0.08, from 0.95 in 2017Q2. Lynch Thomas J. Jr. had sold 5,300 shares worth $335,172. (NASDAQ:FSLR) to report earnings on February, 20. Following the transaction, the executive vice president now owns 584,373 shares in the company, valued at approximately $37,031,717.01. Barclays Plc, a United Kingdom-based fund reported 17 shares. Donaldson Cap Ltd Company invested in 13,824 shares or 0.09% of the stock. Also, Director Theodore R. Samuels II acquired 4,000 shares of the business's stock in a transaction on Friday, December 15th. Steinberg Global Asset Management owns 15,491 shares for 0.15% of their portfolio. Ameritas Inv holds 0.02% in A. O. Smith Corporation (NYSE:AOS) or 7,695 shares.
A number of other large investors have also recently made changes to their positions in the stock. Highland Capital Limited Com has 10,096 shares for 0.05% of their portfolio. Bainco Investors has 0.7% invested in Cisco Systems, Inc. (NYSE:AIN). Bessemer Grp invested 0% of its portfolio in Albany International Corp. Supplemental Annuity Collective Of Nj owns 22,000 shares.More news: Wal-Mart Stores, Inc. (NYSE:WMT) Shares Bought by Foster & Motley Inc
More news: Zac Brown Band will return to the Lakeview Amphitheater
More news: Evidence of Black Holes Feeding in Cycles Described Graphically as Repeated Burps
When we look at the Analyst Recommendations of the stock, the company has 2.4 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell. Therefore 21% are positive. J&J Snack Foods had 12 analyst reports since December 16, 2015 according to SRatingsIntel. The company was maintained on Monday, September 18 by Cowen & Co.
In other news, EVP Sandra Leung sold 156,582 shares of the firm's stock in a transaction on Monday, December 4th. Firm's net income measured an average growth rate of 4.20%. Analysts forecast that Bristol-Myers Squibb Company will post $2.81 earnings per share for the current year. The biopharmaceutical company reported $0.63 EPS for the quarter, missing analysts' consensus estimates of $0.67 by $0.04. A company with higher PE ratio is more worthy against a company with lower PE ratio.
Shares of Bristol-Myers Squibb Company (NYSE:BMY) traded up 0.66% on Wednesday, reaching $52.00. Out of 19 Wall Street analysts rating Bristol-Myers Squibb Company, 6 give it "Buy", 3 "Sell" rating, while 10 recommend "Hold". Therefore 67% are positive.
Ratings analysis reveals 32% of Bristol-Myers Squibb Company's analysts are positive. On Thursday, July 27 the stock rating was maintained by Leerink Swann with "Buy". Barclays Capital maintained the shares of PBR in report on Tuesday, October 10 with "Underweight" rating. The firm has "Hold" rating by Hilliard Lyons given on Tuesday, September 12. BMO Capital Markets downgraded the shares of BMY in report on Monday, January 25 to "Market Perform" rating. The firm has "Buy" rating by Citigroup given on Tuesday, October 6. On Thursday, July 27 the stock rating was maintained by Piper Jaffray with "Hold". During the last 52 weeks, the (NYSE:BMY) price has been as high as $66.1 and as low as $46.01. The firm has "Buy" rating given on Monday, October 30 by SunTrust. Dupont Capital Management Corporation stated it has 0.16% of its portfolio in Cisco Systems, Inc. Caldarella Joseph C had sold 9,340 shares worth $560,400.
Investors sentiment increased to 1.03 in Q3 2017. Its up 0.08, from 0.95 in 2017Q2. It improved, as 62 investors sold BMY shares while 519 reduced holdings. 137 funds opened positions while 460 raised stakes. Alphamark Limited reported 0.02% in Bristol-Myers Squibb Company (NYSE:BMY). Vanguard accumulated 121.79 million shares. Waldron Lp has invested 0.07% in Bristol-Myers Squibb Company (NYSE:BMY). (NASDAQ:CSCO). Janney Management Limited Com has invested 1.04% in Cisco Systems, Inc. Carnegie Asset Mngmt Ltd Liability Co has invested 1.45% in Cisco Systems, Inc. Following the transaction, the director now owns 22,000 shares in the company, valued at $1,370,600. 3 analysts say it's a Hold while 0 analysts provided their expert opinion as Sell. 6,112 were accumulated by Marathon Cap Management. Sumitomo Life Insur holds 54,978 shares. South Carolina-based Greenwood Associate Limited Liability Corp has invested 0.99% in Bristol-Myers Squibb Company (NYSE:BMY). Minneapolis Port Mngmt Limited Co owns 5.6% invested in Cisco Systems, Inc.